Research
Patients with meat allergy who take omalizumab may see improvement of symptoms
The Brief
- Alpha-gal syndrome (AGS), a meat allergy, has risen in cases after bites from the lone star tick, according to the source article.
- The summer of 2026 was described as a particularly bad season for ticks.
- A new study presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual Meeting reports that omalizumab may improve symptoms in patients with meat allergy who take it.
Why it matters
It points to a possible treatment option for a condition linked to tick bites, which appears to be increasing. The available excerpt gives few details on the study's size or results, so the evidence should be treated as preliminary.
Who’s affected
- people with alpha-gal syndrome or meat allergy
- allergists and clinicians who treat food allergies
- #allergy
- #alpha-gal syndrome
- #omalizumab
- #ticks
- #meat allergy
The summer of 2026 was a particularly bad season for ticks. And with it came a rising number of cases of alpha-gal syndrome (AGS) thanks to bites from the lone star tick. A new study presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2026 Annual…